School of Medicine
Showing 1-50 of 130 Results
life Science Research Professional, Rad/Neuroimaging and Neurointervention
Bio Life Science Research Professional 1 ( LRSP1 )Stanford University, Prof. Tarik Massod 2015 - Present
School of Medicine, Department of radiology section of Neuroradiology,
Moleuclar imaging program at Stanford (MIPS) Lab
• Performed antioxidant project to treat brain/breast cancer
• Enhanced the therapeutic ecacy
of Temozolomide (cli/Users/zahraa/Desktop/resumes/Seyedeh
Rayhaneh Afjei/Seyedeh Rayhaneh Afjei.texnical drug) towards glioblastoma by 20 with miR-21
downregulation and PLGA nanoparticles
• Co-delivery of therapeutic microRNAs and drugs for triple negative breast cancer treatment in
pre-clinical small animal model by multifunctional polymer nanocarriers
• Performed Cellular and Molecular Biology techniques including :
- Cell cultureing (T98G, LN229, U87, T98G, 293T,MDA, Hela cells) experiments
- Maintenance of cells, transfection, transduction and drug treatment
- Cloning, transformation, plasmid extraction, gel electrophoresis
- Flow cytometer, mitochondria staining, luciferase assay
- Nanomedicine, Molecular imaging, Targeted delivery, Gene therapy
Assistant to the chair, Spiritual Care, UC Davis Med Center 2012 - Present
Research Assistant, Stanford University, Prof. Ahmad Salehi 2013 - 2015
• BDNF signaling in mouse model of Down syndrome:
Performed biochemical techniques including western blots, immunohistochemistry, qPCR and
• Study di↵erences between normal and abnormal physiology to find appropriate biological targets
for drug intervention
• Study the pathways by which the drugs are causing the observed e↵ects on cognitive function
• Performed in-vitro and in-vivo experiments using mouse models of Down syndrome to study the
e↵ects of drugs on neurodegeneration and learning ability (cognition)
Research Assistant, University of California Davis, Prof. Kit Lam 6/2012-12/2012
Performed experiments on cancer treatment techniques including:
Library design, General library screening techniques, Optimizing concentration of dye
Image j, picked up beads, sequencing
Research Assistant, University of Tehran, Plant Physiology Lab, Prof. Mirmassomi 2000-2004
- Performed research in plant genetics, DNA extraction, plant tissue culture (Walnut), spectrophotometry,
flamephotometry, complexometry, analysis Photosynthetic Pigments, thin layer chromatography
(TLC), recognition?of respiratory enzymes in plants, quantitative determination of protein, PCR,
electrophoresis, plant gene transmission (African violet)
- Hands on the techniques in animal physiology, histology, embryology, and developmental biology
Teacher Assistant, University of Tehran, Genetics lab 2000-2004
Performed experiments in genetics with Drosophila, including preparation and maintenance of cell
culture, techniques in handling flies and conducting experiments with them, preparation of salivary
chromosome, mating preferences and sexual isolation
EDUCATION University of Tehran, BSc in Biology, speciality in Zoology 2002
Selected courseworks :Genetics (course and lab), Cell and molecular biology (course and lab),
The University of Texas at Austin , Attended undergraduate program classes 2000
Selected courseworks : Cellular and Molecular Biology (Grade A), Genetics
PATENTS The use of transdermal formoterol for the treatment of depression in humans 2/2015,
Demir Akin, D.V.M., Ph.D.
Deputy Director, Center for Cancer Nanotechnology Excellence, Rad/Molecular Imaging Program at Stanford
Current Role at Stanford Deputy Director, Center for Cancer Nanotechnology Excellence
Life Science Rsch Prof 1, Rad/Canary Center at Stanford for Cancer Early Detection
Current Role at Stanford Life Science Research Professional -1
Rachelle Bitton, PhD
Physical Sci Res Assoc, Rad/Radiological Sciences Laboratory
Current Role at Stanford •Original research focusing on applications of MR guided Focused Ultrasound (MRgFUS) for ablative treatments of cancer and trans-cranial neurosurgical treatment of tremor.
•Developing new MRI imaging strategies and pulse sequence development of non-ablative applications of focused ultrasound, including MR Acoustic Radiation Force Imaging.
•Medical Physicist including ultrasound treatment planning and MRI imaging specialist of multiple ongoing human clinical trials, as well as clinical treatments at SHC, to image, treat, and monitor MRgFUS of bone metastases, soft tissue tumors of the extremities, uterine fibroids, and trans-cranial MRgFUS treatment of essential tremor.
•Bridge technical and clinical communication as a go between in collaborations with clinicians, interventional radiologists, imaging technologists, medical device companies, and research scientists, graduate students, and faculty.
Physical Sci Res Assoc, Rad/Musculoskeletal Imaging, Rad/Musculoskeletal Imaging
Bio Please visit My Personal Site and the JOINT Group Website (Links on the right)
Research scientist, Rad/Radiological Sciences Laboratory
Current Role at Stanford Offline data reconstruction and display; architecture and programming support for clinical research MR scans; image data transfer; image display; troubleshooting; data encryption and security.
RESIDENT, HS-DIAG RADIOLOGY-SHC
Rami El Assal
Basic Life Research Scientist, Rad/Canary Center at Stanford for Cancer Early Detection
Bio Dr. El Assal is a Basic Life Research Scientist (Academic Staff) at the Canary Center for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine. In 2016, Dr. El Assal completed a Postdoctoral Research Fellowship at Stanford University School of Medicine. Before moving to Stanford, he was working as a Postdoctoral Research Fellow in Medicine at Harvard Medical School, and Brigham and Women’s Hospital, Boston, MA as well as the Harvard-MIT Health Science and Technology division. In 2016, Dr. El Assal completed a Certificate Program in Innovation and Entrepreneurship at the Stanford Graduate School of Business. Dr. El Assal received his Doctor of Dental Surgery (D.D.S.) degree from Ajman University of Science and Technology (AUST), School of Dentistry, Ajman, UAE in 2007. Subsequently, He completed a one-year Clinical Internship Program in General Dentistry at Royal College of Surgeons in Ireland (RCSI)-affiliated training center at AUST-School of Dentistry. Following his internship, he enrolled in an Advanced Education Program in General Dentistry for two years (2008-2010). His research interests revolved around the applications of nano-/micro-scale technologies and biomaterials in medicine, including regenerative and transfusion medicine as well as cancer research. He has published his research work in esteemed peer-reviewed journals and conference proceedings, including Advanced Materials (Impact Factor (IF): 19.79), Materials Today (IF: 21.69), Nanomedicine, Biotechnology Journal, Biofabrication Journal, ACS Molecular Pharmaceutics, Lab on a Chip, and Scientific Reports (from Nature Publishing Group). His research achievements have been recognized by the Center of Nanoscale Systems (CNS) at Harvard University. In 2015, Dr. El Assal has been nominated/elect as a Fellow of the Academy of Dentistry International (USA), International International Academy for Dental-Facial Esthetics (USA), and International Academy of Oral Oncology (UK). Dr. El Assal has a multifaceted and challenging career in research and patient care, and he is now aspiring to a career that will help fulfill his ambition of being an effective teacher, researcher, and clinician. His ultimate goal, along with treating patients on an individual basis, is to be able to treat them on a larger scale through establishing a world-class research facility that develop innovative solutions to clinical problems. During his free time, Dr. El Assal likes to help the people and serve the community.
Nicole Foster "Nikki"
Administrative Associate 2, Radiology
Current Role at Stanford I am an Administrative Associate, supporting Dr. Daniel Rubin, an Assistant Professor of Radiology and Medicine (Biomedical Informatics Research)
Clinical Research Project Manager, Rad/Molecular Imaging Program at Stanford
Current Role at Stanford Clinical Research Project Manager
Research Engineer, Rad/Pediatric Radiology
Bio Dr. Herickhoff has worked in ultrasound R&D in academia and industry since 2005. His research interests include IVUS transducer design and imaging methods, "Smart" 3D ultrasound (image acquisition methods, reconstruction techniques, improved display, and automated diagnosis), and capacitive micromachined ultrasonic transducers (cMUTs).
Research Engineer, Rad/Pediatric Radiology
Bio My research interests are focused on developing and implementing novel beamforming techniques to improve the quality and diagnostic value of ultrasound images. Current projects include improving image quality in difficult-to-image patients, enhancing the sensitivity of molecular contrast-enhanced ultrasound imaging, reducing common artifacts in ultrasound imaging using machine learning-based methods, and the rapid translation of these techniques onto real-time ultrasound imaging systems using GPU-based computing.
Basic Life Sci Res Assoc, Rad/Canary Center at Stanford for Cancer Early Detection
Current Role at Stanford Dr. Fatih Inci’s area of excellence in research is to create micro- and nano-scale platform technologies at the intersection of medicine, biomedical engineering, biotechnology, chemistry, and materials science by manipulating biomolecules, cells and viruses in small volumes that offers precise solutions for real-world challenges in clinical diagnostics, personalized medicine, early cancer detection, forensic science, and biomarker discovery.
SOME OF THE RESEARCH HIGHLIGHTS and NEWS
•New device selects healthy sperm (Stanford Medicine) (2018).
•WPI Researchers Play Critical Role to Create Sperm-Sorting Device That Could Improve IVF Success (Worcester Polytechnic Institute) (2018).
•Sperm ‘obstacle course’ created by scientists to select healthiest ones for IVF (The Independent UK) (2018).
•Separating the weak from the strong: New device sorts sperm (Scope by Stanford Medicine) (2018).
•Interview on Istanbul University, Science Faculty - Faculty Guide (2017).
•Bioengineering and Biomedicine - Interview on Crossing Paths (2017).
•RöporTAF Interview on TAV Network (2017).
•Scientists develop new HIV diagnostic device (Johns Hopkins News-Letter) (2016).
•Potential point-of-care diagnostic platform (EurekAlert – Science AAAS) (2015).
•A New Platform for Point-of-Care Diagnostics? (Optics&Photonics News) (2015).
•Universelle Diagnostik: Ein Bluttest für alles (Deutschlandfunk) (2015).
•Smarter, Cheaper Technologies Offer Improved Point-of-care Medicine (NIH – National Institue of Biomedical Imaging and Bioengineering) (2015).
•New HIV Test May Improve Point-of-care Medicine in Remote Regions (Journal of the American Medical Association (JAMA)) (2015).
•New Biosensing Platform to be used in Disease Detection (Dartmouth University)
•Paper and Phones Could Soon Diagnose Ebola and HIV for $1 (Newsweek) (MSN News) (2015).
•Biosensing Films and Smartphones Let Doctors Diagnose Disease from Anywhere (Popular Science) (2015).
•Bientôt un diagnostic médical avec son smartphone (Futura Sciences) (2015).
•Novel Biosensing Platform Could Remotely Diagnose Disease And Monitor Treatment (BioSpace) (2015).
•Smarter, cheaper technologies for improved point-of-care medicine in remote areas (Kurzweil Accelerating Intelligence) (2015).
•App may detect bacterial infections (TV news in WPLG TV, an affiliate of ABC News) (2015).
•Un sistema permite diagnosticar enfermedades por el cellular (Investigacion y Desarrollo) (2015).
•Smartphone accessory puts HIV diagnosis in doctors' pockets (Engadget) (2015).
•Cell Phone App Detects Bacteria and Infectious Diseases (HCP Live) (2015).
•New Biosensing Platform Could Quickly and Accurately Diagnose Disease and Monitor Treatment Remotely (Florida Atlantic University) (2015).
•Smart phone diagnosis? Biosensing platform quickly and accurately diagnoses disease and monitors treatment remotely (ScienceDaily) (2015).
•Smartphone App Detects Bacteria, Diseases (Highlights in Product, Design & Development) (Nature World News) (2015).
•Novel biosensing platform could remotely determine treatment options for HIV, E-coli (News-Medical Net) (2015)
•Nanomechanical motion of Escherichia coli adhered to a surface – (Canary Center at Stanford Newsletter) (2014).
•And so they beat on, flagella against the cantilever – (American Institute of Physics) (Phys.org) (EurekAlert – Science AAAS) (ScienceDaily) (Kurzweil Accelerating Intelligence) (2014).
•It’s flagella against the Cantilever for the fate of bacteria – (Boston University) (Science 2.0) (2014).
•Palo Alto Weekly - Stoking a passion for science (News Cover) (2014).
•Disposable Chips to Detect Antiepileptic Drug Serum Concentrations at the Point of Care using Nanoplasmonic Platform – Brigham & Women’s Hospital, BRIght Future Prize (Nature Medicine) (Brigham & Women’s Hospital) (2013).
Deputy Director, Molecular Imaging Program at Stanford (MIPS), Rad/Molecular Imaging Program at Stanford
Current Role at Stanford Deputy Director, Molecular Imaging Program at Stanford (MIPS)
Jeffrey Howard Kleck
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
Bio Jeff Kleck (Menlo Park, CA) is an Adjunct Professor in the School of Medicine. He is also one of the Silicon Valley's leading healthcare technology and software entrepreneurs. He was most recently President of iSchemaView (privately held). Before building iSchemaView he was Founder and the CEO and Chairman of Attainia (acquired by private equity). Prior to Attainia he was Founder and the CEO and Chairman of Neoforma (NASDAQ: NEOF), which was purchased by GHX (privately held). Before Neforma he held two management positions at Varian (NYSE: VAR). Dr. Kleck holds a PhD in Biomedical Physics from UCLA (former faculty), an MS in Engineering Management from Stanford University (current faculty), and an MS and a BS in Nuclear Engineering from Texas A&M University (current advisor). He also holds numerous certifications, licenses, and patents.